Stay updated on OpACIN-neo Optimal Combo Trial

Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.
Latest website image capture
Clouds background image

Latest updates to the OpACIN-neo Optimal Combo Trial page

  1. Check
    today
    Change Detected
    Summary
    Administrative updates: a new system revision (v3.4.2) is added, and older notices (including a funding-lapse alert and revision v3.4.1) are removed. These changes do not alter study details.
    Difference
    0.4%
    Check dated 2026-02-11T05:08:20.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Added an administrative funding notice and a 2026 Nat Med publication citation to Publications, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:43:19.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a glossary and includes minor text/capitalization updates (Last Update Submitted that Met QC Criteria vs met QC Criteria, No FEAR Act Data), and the Revision label updated to v3.4.0 from v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:44:06.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:13:08.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Locations section now includes New South Wales (Australia) and North Holland (Netherlands) as study sites. The footer HHS Vulnerability Disclosure link was removed and the page revision was updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T09:21:54.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Added status history and sponsor details to the study page, including 'Last known status was:', 'The Netherlands Cancer Institute', date '2023-11', and 'Verified'.
    Difference
    0.3%
    Check dated 2025-12-01T18:41:39.000Z thumbnail image

Stay in the know with updates to OpACIN-neo Optimal Combo Trial

Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.